Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -233.43% is in line with its 5-year average of -237.20%, around the middle of its 5-year range (-335.90%–-178.58%).
21.85% above its 12-month average of -298.69%.
Reported quarterly return on assets; no daily interpolation. Q3 FY2026 (2026-06-30): -77.60%.
RETURN ON ASSETS (ROA)
-233.43%
RETURN ON ASSETS (ROA) AVG TTM
-298.69%
RETURN ON ASSETS (ROA) AVG 3Y
-252.88%
RETURN ON ASSETS (ROA) AVG 5Y
-237.20%
RETURN ON ASSETS (ROA) AVG 10Y
-234.58%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+21.85%
CURRENT VS 3Y AVG
+7.69%
CURRENT VS 5Y AVG
+1.59%
CURRENT VS 10Y AVG
+0.49%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-624.04%
vs the sector median at left
Outlook Therapeutics, Inc.
Market Cap
$107.73M
Return on Assets (ROA)
-233.43%
TTM Avg
-298.69%
3Y Avg
-252.88%
5Y Avg
-237.20%
Market Cap
$107.79M
Return on Assets (ROA)
-63.19%
TTM Avg
-62.03%
3Y Avg
-51.81%
5Y Avg
-103.22%
Market Cap
$107.89M
Return on Assets (ROA)
-85.80%
TTM Avg
-37.85%
3Y Avg
-56.27%
5Y Avg
-56.27%
Market Cap
$106.11M
Return on Assets (ROA)
-70.09%
TTM Avg
-324.97%
3Y Avg
-229.15%
5Y Avg
-168.27%
Market Cap
$105.99M
Return on Assets (ROA)
-80.25%
TTM Avg
-36.24%
3Y Avg
-78.62%
5Y Avg
-77.58%
Market Cap
$105.63M
Return on Assets (ROA)
-16.87%
TTM Avg
-6.13%
3Y Avg
-6.48%
5Y Avg
-5.59%
Market Cap
$109.49M
Return on Assets (ROA)
-14.14%
TTM Avg
-26.48%
3Y Avg
-30.34%
5Y Avg
-26.58%
Market Cap
$104.67M
Return on Assets (ROA)
-57.98%
TTM Avg
-386.38%
3Y Avg
-312.00%
5Y Avg
-312.00%
Market Cap
$104.03M
Return on Assets (ROA)
-33.85%
TTM Avg
-28.41%
3Y Avg
-17.06%
5Y Avg
-12.28%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | $107.73M | -233.43% | -298.69% | -252.88% | -237.20% |
| Vivani Medical, Inc. (VANI)vs › | $107.79M | -63.19% | -62.03% | -51.81% | -103.22% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $107.89M | -85.80% | -37.85% | -56.27% | -56.27% |
| Immunic, Inc. (IMUX)vs › | $106.11M | -70.09% | -324.97% | -229.15% | -168.27% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $105.99M | -80.25% | -36.24% | -78.62% | -77.58% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $105.63M | -16.87% | -6.13% | -6.48% | -5.59% |
| Apyx Medical Corporation (APYX)vs › | $109.49M | -14.14% | -26.48% | -30.34% | -26.58% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.67M | -57.98% | -386.38% | -312.00% | -312.00% |
| Definitive Healthcare Corp. (DH)vs › | $104.03M | -33.85% | -28.41% | -17.06% | -12.28% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.00M | -34.04% | -20.59% | -37.88% | -37.10% |
ROA
-233.4%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-09-30 | -335.90% |
| 2024-09-30 | -261.48% |
| 2023-09-30 | -182.61% |
| 2022-09-30 | -231.54% |
| 2021-09-30 | -233.06% |
| 2020-09-30 | -178.58% |
| 2019-09-30 | -201.48% |
| 2018-09-30 | -135.04% |
| 2017-09-30 | -187.37% |
| 2016-09-30 | -224.85% |
| 2015-09-30 | -408.43% |
| 2014-09-30 | -39.22% |
